Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata,Japan, in 2014 |
| |
| Authors: | Shizuka Tanaka Yoko Aoki Yohei Matoba Kazue Yahagi Tsutomu Itagaki Yoko Matsuzaki Katsumi Mizuta |
| |
| Affiliation: | 1. Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, 990‐0031;2. Yamanobe Pediatric Clinic, Yamanobe, Yamagata, 990‐0301;3. Department of Infectious Diseases, Yamagata University Faculty of Medicine, Iida‐Nishi, Yamagata, 990‐9585, Japan |
| |
| Abstract: | To clarify the seroepidemiology of human parechovirus type 1 (HPeV1), 3 and 6, neutralizing antibodies (NT Abs) were measured in 214 serum specimens collected in 2014 in Yamagata, Japan. The seroprevalence against HPeV1 was 100% in all age groups, while that against HPeV3 and HPeV6 was 79.4% and 66.8%, respectively, overall. The geometric mean titers of NT Abs against HPeV1, 3 and 6 were 755.2, 255.0 and 55.9, respectively, overall. Our findings indicate that HPeV1 is the most prevalent HPeV circulating in Yamagata, followed by HPeV3 and HPeV6. |
| |
| Keywords: | emerging disease human parechovirus seroepidemiology |
|
|
